XNAS · Laboratory Analytical Instruments · S&P 500
$0.49
+$0.00 (+0.12%) today
Open $0.49 High $0.51 Low $0.48 Vol 203K Avg $0.50
Find similar stocks by technical condition — S&P 500 universe
| Symbol | Company Name | Exchange | Currency | Category |
|---|---|---|---|---|
| STEX | Streamex Corp. Common Stock | XNAS | USD | ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS |
| NRXS | Neuraxis, Inc. | XASE | USD | ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS |
| NXL | Nexalin Technology, Inc. Common Stock | XNAS | USD | ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS |
| OM | Outset Medical, Inc. Common Stock | XNAS | USD | ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS |
| CBLL | CeriBell, Inc. Common Stock | XNAS | USD | ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS |
| QTI | QT Imaging Holdings, Inc. Common Stock | XNAS | USD | ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS |
52-week price range
Price is 61.1% above its 52-week low and 75.4% below its 52-week high. Trading in the lower half of its annual range — closer to the floor than the ceiling.
Nexalin Technology Inc designs and develops neurostimulation products to uniquely and effectively help combat the ongoing mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.